A previous Notice to the Bar sought comments on an application for the designation of all New Jersey state-court litigation involving allegations of liver injuries caused by Tylenol products as Multicounty Litigation ("MCL"). That application was submitted pursuant to Rule 4:38A and the Revised Multicounty Litigation Guidelines as promulgated by Directive No. 8-12. This Notice is to advise that the Supreme Court, after considering the application and all comments received, has determined not to grant the application. Accordingly, all cases involving allegations of liver injuries caused by Tylenol products should continue to be filed in the appropriate counties of venue.

This Notice will also be posted on the Judiciary's Internet website (njcourts.com) in the Multicounty Information Center ( http://www.judiciary.state.nj.us/mass-tort/index.htm).

Questions concerning this matter may be directed to Taironda E. Phoenix, Esq., Chief, Civil Court Programs, Administrative Office of the Courts, Hughes Justice Complex, P.O. Box 981, Trenton, New Jersey 08625-0981; telephone (609) 292-8471; email address taironda.phoenix@judiciary.state.nj.us.

Glenn A. Grant, J.A.D.
Acting Administrative Director of the Courts

Dated: July 31, 2013